TOP TIERMARKET NEWSWIRE
SEC Form 4 history

CRESCENT BIOPHARMA I (CBIO) insider trades

CRESCENT BIOPHARMA I (CBIO) insider trading activity (SEC Form 4). Over the trailing 90 days, CBIO insiders filed 1 purchases totalling $12.4M and 7 sales totalling $1.2M — net BUYING of $11.1M. Most recent filing: Jul 20, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
1
$12.4M
Sells (90d)
7
$1.2M
Net (90d)
+$11.1M
net buying
Most recent
Jul 20, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Jul 20, 2026Fairmount Funds Management LLCDir, 10%P Purchase—$14.50$12.4Mfiling
Jun 23, 2026Lynch RyanSee RemarksS Sale—$17.99$8Kfiling
Jun 23, 2026Brumm Joshua TCEOS Sale—$17.99$761Kfiling
Jun 23, 2026McNeill JonathanPres, COOS Sale—$17.99$370Kfiling
Jun 23, 2026Im Ellie EunkyungChief Medical OfficerS Sale—$17.99$22Kfiling
Jun 23, 2026Bispham Barbara HarlinSee RemarksS Sale—$17.99$22Kfiling
Jun 23, 2026Scalzo Richard WilliamCFOS Sale—$17.99$20Kfiling
Jun 23, 2026Pinkas JanChief Scientific OfficerS Sale—$17.99$23Kfiling